Clinical Trials Browser

Phase 2 × Carcinoma, Neuroendocrine × Carboplatin × Clear all

NCT02595424 2025-12-29

Cisplatin and Etoposide Versus Temozolomide and Capecitabine in Patients With Advanced Poorly Differentiated (G3) Non-Small Cell Gastrointestinal Neuroendocrine Carcinomas

Phase 2 Active not recruiting

Somatostatinoma, Carcinoma, Neuroendocrine

NCT04325425 2025-09-30

FOLFIRINEC

Phase 2 Recruiting

Carcinoma, Neuroendocrine

NCT04268121 2025-07-23

NEONEC

Phase 2 Recruiting

EndocrineGastrointestinal

Gastrointestinal Neoplasms, Carcinoma, Neuroendocrine

NCT00193531 2023-04-11

Paclitaxel, Carboplatin, and Oral Etoposide Followed by Weekly Paclitaxel in High Grade Neuroendocrine Carcinoma

Phase 2 Completed

Carcinoma, Neuroendocrine